Product Detail
(2R,3S)-N-Benzoyl-3-phenyl Isoserine Ethyl Ester
Paclitaxel Impurity
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Impurity
API Family
Paclitaxel
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
(2R,3S)-N-Benzoyl-3-phenyl Isoserine Ethyl Ester Product Information
(2R,3S)-N-Benzoyl-3-phenyl Isoserine Ethyl Ester is listed under Impurity. It is associated with Paclitaxel and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-48736.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
(2R,3S)-N-Benzoyl-3-phenyl Isoserine Ethyl Ester
CAS No.
153433-80-8
CAT No.
CS-T-48736
Molecular Formula
C₁₈H₁₉NO₄
Molecular Weight
313.35
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O[C@@H](C(OCC)=O)[C@@](C1=CC=CC=C1)([H])NC(C2=CC=CC=C2)=O
IUPAC Name
Ethyl (2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate
Purity by HPLC
98.07%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Intermediate of Paclitaxel. (2R,3S)-N-Benzoyl-3-phenylisoserine ethyl ester is an intermediate in the preparation of potent anticancer drug Paclitaxel used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine ethyl ester shows cytotoxic, antiviral and immunomodulatory activity."
Synonyms
-
Application Notes
"Intermediate of Paclitaxel. (2R,3S)-N-Benzoyl-3-phenylisoserine ethyl ester is an intermediate in the preparation of potent anticancer drug Paclitaxel used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine ethyl ester shows cytotoxic, antiviral and immunomodulatory activity."
References
"Paal, K, et al,: Bioorg, Med, Chem,, 15, 1323 (2007); Krawczyk, E, et al,: J, Pharm, Pharmacol,, 57, 791 (2005); "
